We demonstrated that in this population, elevated adiponectin and NT-proBNP were positively associated with increased risk for HF hospitalization and CVD mortality despite a more favorable cardiometabolic profile, including less diabetes and obesity. Here, ADIPOQ is linked to Obesity.